Events & Presentations Upcoming Events No upcoming events at this time Past Events Silverback Therapeutics and ARS Pharmaceuticals Merger Announcement Jul 21, 2022 at 2:00 PM PDT Click here for webcast Silverback Therapeutics and ARS Pharmaceuticals Merger Announcement Presentation 4.2 MB Investor Presentations ARS Pharmaceuticals - Corporate Presentation ARS Pharmaceuticals - Corporate Presentation 5.6 MB Scientific Presentations ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB ACAAI 2022 Poster 238 Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection 2.2 MB AAAAI 2022 Poster 009 The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy ) Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis 346 KB ACAAI 2022 Poster 236 Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB AAAAI 2022 Poster 007 Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
Investor Presentations ARS Pharmaceuticals - Corporate Presentation ARS Pharmaceuticals - Corporate Presentation 5.6 MB Scientific Presentations ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB ACAAI 2022 Poster 238 Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection 2.2 MB AAAAI 2022 Poster 009 The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy ) Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis 346 KB ACAAI 2022 Poster 236 Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB AAAAI 2022 Poster 007 Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB
Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection 2.2 MB
The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy ) Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis 346 KB
Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB
Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB
Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB
Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB
ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
